Evidence map›Paper›PMID 37935562›Full record

ArticleOpen heart2023

Left ventricular hypertrophy: an ECG-based study of prevalence and risk factors in a multiethnic population.

Hina Taki, Jaakko Tuomilehto, Paul Zimmet, Abdonas Tamosiunas, Sudhir Kowlessur, Dianna J Magliano, Jonathan E Shaw, Stefan Söderberg, Ulf Nilsson

Open access · goldAbstract read
In one paragraph

Article in Open heart, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 5 countries.

Hina TakiDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Jaakko TuomilehtoPublic Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Paul ZimmetDepartment of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia.ORCID 0000-0003-0627-0776
Abdonas TamosiunasInstitute of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Sudhir KowlessurMinistry of Health and Wellness, Port Louis, Mauritius.
Dianna J MaglianoDiabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Jonathan E ShawDiabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Stefan SöderbergDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.ORCID 0000-0001-9225-1306
Ulf NilssonDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden ulf.nilsson@umu.se.ORCID 0000-0002-2574-479X
Umeå University · SEBaker Heart and Diabetes Institute · AULithuanian University of Health Sciences · LTMinistry of Health and Quality of Life · MUMonash University · AUUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeft ventricular hypertrophy (LVH) is frequently seen in association with arterial hypertension and indicates poor prognosis. This study aimed to determine the prevalence of LVH and associated factors in a multiethnic population from Mauritius.

methodsPopulation-based health surveys were performed in 2009 and 2015 and included in total 8961 individuals aged 35-75 years with recorded 12-lead ECG. LVH was defined according to three criteria: Sokolow-Lyon, Cornell voltage and Cornell product. Data were collected about health and lifestyle behaviour. Anthropometry and blood pressure were measured. Fasting levels of blood lipids and glucose were determined, oral glucose tolerance test was performed in people without glucose-lowering medications.

resultsThe age-standardised prevalence of LVH was 9% (n=875) according to any of the three ECG criteria. Individuals with LVH were older, more likely to have hypertension, diabetes, known cardiovascular disease (CVD) and elevated levels of cholesterol and creatinine. Further, they were more likely to be of African descent (Creole) and have lower educational level. In a multivariable model, Creole (OR (95% CI)) (1.56 (1.33 to 1.83)), low educational level (1.49 (1.28 to 1.75)), hypertension (3.01 (2.55 to 3.56)), known CVD (1.42 (1.11 to 1.83)) and elevated creatinine (1.08 (1.03 to 1.14)) remained associated with LVH. Individuals with non-treated or uncontrolled hypertension had a higher risk for LVH (3.09 (95% CI 2.57 to 3.71) and 4.07 (95% CI 3.29 to 5.05), respectively), than individuals with well controlled hypertension or normotension.

conclusionLVH occurs more frequently in individuals with hypertension, as well as in individuals with African ancestry and/or low education level.

Indexed as

Cardiovascular DiseasesHypertensionCreatinineElectrocardiographyGlucoseHumansHypertrophy, Left VentricularPrevalenceRisk FactorsCreatinineGlucoseDiabetes MellitusElectrocardiographyEPIDEMIOLOGYHypertension

Identifiers

PMID37935562
PMCPMC10632900
OpenAlexW4388465554

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.